文献速递神经儿科影像MR

儿童中枢神经系统奈拉滨毒性影像表现

Imaging Findings in Children Presenting with CNS Nelarabine Toxicity.
PubMed 文献 · AJNR Am J Neuroradiol · 2022-11-03

本文回顾了6例T细胞急性淋巴细胞白血病患儿接受奈拉滨治疗后出现临床神经毒性并接受脑和/或脊髓MR检查的影像表现。神经影像呈现多种模式混合,包括急性中毒性白质脑病(6例)、可逆性后部脑病综合征(2例)、深部灰质受累(1例)、脑干受累(2例)、颅神经和脊神经病(各2例)及脊髓病(2例)。作者旨在提醒儿科神经影像医生、放射科医生和临床医生注意奈拉滨所致神经毒性及其广泛影像谱。

要点

  • 奈拉滨治疗T-ALL后出现神经症状的患儿需警惕药物神经毒性,MR表现多样。
  • 急性中毒性白质脑病是最常见模式,本组6例均可见。
  • 可逆性后部脑病综合征、深部灰质和脑干受累、颅/脊神经病及脊髓病亦可出现。

局限性

  • 样本量小(6例),结论有限。
  • 回顾性研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Nelarabine is a nucleoside analog critical for the treatment of patients with T-cell acute lymphoblastic leukemia/lymphoma. However, clinical peripheral and central neurologic adverse events associated with nelarabine administration have been reported. Neuroimaging of brain neurotoxicity has only been described in very few reports in pediatric patients so far. Six children with diagnosed T-cell acute lymphoblastic leukemia who clinically experienced possible, probable, or definite nelarabine-induced toxicity and underwent spine and/or brain MR imaging were reviewed. Neuroimaging findings showed a mixture of patterns including features of acute toxic leukoencephalopathy (seen in 6 cases), posterior reversible encephalopathy syndrome (2 cases), involvement of deep gray structures (1 case) and brainstem (2 cases), cranial and spinal neuropathy (2 cases each), and myelopathy (2 cases). Even though neuroimaging findings are nonspecific, the goal of this article was to alert the pediatric neuroradiologists, radiologists, and clinicians about the possibility of nelarabine-induced neurotoxicity and its broad neuroimaging spectrum.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Serrallach, Schafer, Kralik, et al. Imaging Findings in Children Presenting with CNS Nelarabine Toxicity. AJNR Am J Neuroradiol. 2022. PMID: 36328408. doi:10.3174/ajnr.A7692

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。